Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis.

Abstract

Plasma levels of macrophage derived sCD163 are associated with disease activity and predict radiographic progression in early RA patients, supporting that sCD163 may have a role as a biomarker of disease activity and that resident macrophages are important for joint destruction.